par Benhadou, Farida
;Mintoff, DIllon;Schnebert, Benjamin
;Thio, Hok Bing
Référence Diseases (Basel, Switzerland), 6, 2
Publication Publié, 2018-06-01
;Mintoff, DIllon;Schnebert, Benjamin
;Thio, Hok BingRéférence Diseases (Basel, Switzerland), 6, 2
Publication Publié, 2018-06-01
Article révisé par les pairs
| Résumé : | Recent advances have highlighted the crucial role of microbiota in the pathophysiology of chronic inflammatory diseases as well as its impact on the efficacy of therapeutic agents. Psoriasis is a chronic, multifactorial inflammatory skin disorder, which has a microbiota distinct from healthy, unaffected skin. |



